Traws Pharma, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Traws Pharma, Inc. reported Cash And Cash Equivalents At Carrying Value of $21.40 million for the year ending 2016.

  • Traws Pharma, Inc. showed an increase of +8.1% in Cash And Cash Equivalents At Carrying Value from 2015 to 2016.
  • This data is from Traws Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 29, 2017.
  • XBRL data for this metric is available from 2010 to 2016 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2010 to 2016), Traws Pharma, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 191.6%.
  • Historical annual values: Fiscal year 2016: $21.40 million | Fiscal year 2015: $19.80 million | Fiscal year 2014: $43.58 million | Fiscal year 2013: $60.01 million | Fiscal year 2012: $81.53 million | Fiscal year 2011: $2.71 million | Fiscal year 2010: $7.34 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: